Evidence map›Paper›PMID 31986257›Full record

ArticleLancet (London, England)2020

A novel coronavirus outbreak of global health concern.

Chen Wang, Peter W Horby, Frederick G Hayden, George F Gao

Erratum issued 14 registry-linked trialsAbstract readComment
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 14 registered trials, which are not on this map. Cited by 3,513 papers.

0numbers the graph read from it
0cells of the map it votes in
3,513citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04316728 naunknown statusnot on this map

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in a Cohort of Negative Patients for Coronavirus Infection for the Early Detection of Positive Antibodies for COVID-19

TypeinterventionalSponsorCentro Studi Internazionali, ItalyRan2020 to 2020Enrolled200ConditionsCoronavirus InfectionsArmsVivaDiag™ COVID-19 lgM/IgG Rapid Test
NCT04360356 phase2 / phase3unknown statusnot on this map

Clinical Trial Evaluating Safety and Efficacy of Ivermectin and Nitazoxanide Combination as Adjuvant Therapy in COVID-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope

TypeinterventionalSponsorTanta UniversityRan2020 to 2020Enrolled100ConditionsCOVID-19ArmsIvermectin plus Nitazoxanide, Standard Care
NCT04361318 phase2 / phase3unknown statusnot on this map

Clinical Trial Evaluating Safety and Efficacy of Hydroxychloroquine and Nitazoxanide Combination as Adjuvant Therapy in Covid-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope

TypeinterventionalSponsorTanta UniversityRan2020 to 2020Enrolled100ConditionsCOVID-19ArmsHydroxychloroquine plus Nitazoxanide, Standard care
NCT04380402 phase2unknown statusnot on this map

Prospective Randomized Open-label Trial of Atorvastatin as Adjunctive Treatment of COVID-19

TypeinterventionalSponsorMount Auburn HospitalRan2020 to 2022Enrolled300ConditionsCOVID-19ArmsAtorvastatin
NCT04443075 completednot on this map

Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress of Fighting Against 2019-nCoV

TypeobservationalSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityRan2020 to 2020Enrolled180ConditionsStress Disorders, Post-TraumaticArmsfaecal sample collector
NCT04459403 completednot on this map

Psychiatric Disturbances in Patients Infected With COVID-19: A Cross Sectional Study

TypeobservationalSponsorCairo UniversityRan2020 to 2020Enrolled400ConditionsCorona Virus Infection
NCT04548557 phase3unknown statusnot on this map

Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial

TypeinterventionalSponsorUniversity of Health Sciences LahoreRan2020 to 2020Enrolled60ConditionsCovid19Armsintravenous immunoglobulin therapy
NCT04769284 completednot on this mapstarted 2021, after this paper: background citation

Psychological State of University Students of Health Sciences During COVID-19

TypeobservationalSponsorYolanda Marcen RomanRan2021 to 2021Enrolled332ConditionsStress, Psychological, Anxiety, Depression, Covid19ArmsMental health student
NCT04780152 phase2 / phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Assessment of Efficacy and Safety of Anodal Transcranial Direct Current Stimulation (TDCS) in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemics

TypeinterventionalSponsorEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezRan2021 to 2022Enrolled172ConditionsMajor Depressive DisorderArmsTranscranial Direct Current Stimulation, Placebo-simulation of transcranial direct current stimulation, Fluoxetine Tablets
NCT04993560 completednot on this mapstarted 2021, after this paper: background citation

Comparing the Safety and Efficacy of Homologous and Heterologous COVID-19 Prime-boost Vaccination in Bahrain

TypeobservationalSponsorRoyal College of Surgeons in Ireland - Medical University of BahrainRan2021 to 2021Enrolled305ConditionsSARS-CoV 2 Infection, Covid19ArmsBBIBP-CorV, BNT162b2
NCT05012267 nacompletednot on this mapstarted 2021, after this paper: background citation

OptiMal pronE Position LEnghT in Patients With acuTE Respiratory Distress Syndrome Due to COVID-19.

TypeinterventionalSponsorIgnacio Saez de la FuenteRan2021 to 2021Enrolled61ConditionsArdsArms16-hour PP
NCT05077306 nacompletednot on this mapstarted 2021, after this paper: background citation

Effect of Musical Listening on Anxiety and Depression in Patients Hospitalized for Covid-19: a Randomized Controlled Trial

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria Consorziale Policlinico di BariRan2021 to 2021Enrolled40ConditionsSARS-CoV2 InfectionArmsmusic therapy group
NCT05293665 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

A Phase 3 Multi-Center International, Randomized, Active-Controlled Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

TypeinterventionalSponsorVaxxinity, Inc.Ran2022 to 2023Enrolled944ConditionsCOVID-19 VaccinesArmsUB-612, BNT162b2 vaccine, ChAdOx1-S vaccine, Sinopharm BIBP
NCT05741099 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

The Application and Research of Mesenchymal Stem Cells in Alleviating the Severe Development of Novel Coronavirus Infection to Clarify Its Safety and Effectiveness.

TypeinterventionalSponsorHebei Medical UniversityRan2023 to 2025Enrolled20ConditionsCOVID-19ArmsUmbilical cord mesenchymal stem cells implantation, Comparator
3 · Its place in the literature

Who cites it

3,513 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Effect of 1% HInternational dental journal · 2024
    Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

3,453 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Chen WangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China. Electronic address: cyh-birm@263.net.
Peter W HorbyCentre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Frederick G HaydenDepartment of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
George F GaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.

Funding

Medical Research Council MC_PC_19056
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusPneumoniaBetacoronavirusCoronavirus InfectionsDisease OutbreaksGlobal HealthHumansSARS-CoV-2

Identifiers

PMID31986257
PMCPMC7135038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 8 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.